Video

Mitigate Risk Of Virus Contaminations In Biopharma Manufacturing

Source: Sartorius Stedim Biotech
sartorius

Virus contaminations of cell cultures can lead to the closure of biopharmaceutical manufacturing facilities. Franz Nothelfer of Boehringer Ingelheim explains, at the European Upstream & Downstream Forum 2016, why growth media filtration with a virus-retentive filter could become the only risk-mitigation method accepted by the regulatory authorities.